A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities

por Montes, Jacqueline, Eichinger, Katy J., Pasternak, Amy, Yochai, Cara, Krosschell, Kristin J.
Publicado 2022

Essential competencies for physical therapist managing individuals with spinal muscular atrophy: A delphi study

por Timmerberg, Jean Fitzpatrick, Krosschell, Kristin J., Dunaway Young, Sally, Uher, David, Yun, Chris, Montes, Jacqueline
Publicado 2021

Systematic Review of Cerebral Palsy Registries/Surveillance Groups: Relationships between Registry Characteristics and Knowledge Dissemination

por Hurley, Donna S, Sukal-Moulton, Theresa, Gaebler-Spira, Deborah, Krosschell, Kristin J, Pavone, Larissa, Mutlu, Akmer, Dewald, Julius PA, Msall, Michael E
Publicado 2015

Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases

por Duong, Tina, Krosschell, Kristin J., James, Meredith K., Nelson, Leslie, Alfano, Lindsay N., Eichinger, Katy, Mazzone, Elena, Rose, Kristy, Lowes, Linda P., Mayhew, Anna, Florence, Julaine, King, Wendy, Senesac, Claudia R., Eagle, Michelle
Publicado 2021

Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy

por Swoboda, Kathryn J., Scott, Charles B., Reyna, Sandra P., Prior, Thomas W., LaSalle, Bernard, Sorenson, Susan L., Wood, Janine, Acsadi, Gyula, Crawford, Thomas O., Kissel, John T., Krosschell, Kristin J., D'Anjou, Guy, Bromberg, Mark B., Schroth, Mary K., Chan, Gary M., Elsheikh, Bakri, Simard, Louise R.
Publicado 2009

SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy

por Kissel, John T., Scott, Charles B., Reyna, Sandra P., Crawford, Thomas O., Simard, Louise R., Krosschell, Kristin J., Acsadi, Gyula, Elsheik, Bakri, Schroth, Mary K., D'Anjou, Guy, LaSalle, Bernard, Prior, Thomas W., Sorenson, Susan, Maczulski, Jo Anne, Bromberg, Mark B., Chan, Gary M., Swoboda, Kathryn J.
Publicado 2011

SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy

por Swoboda, Kathryn J., Scott, Charles B., Crawford, Thomas O., Simard, Louise R., Reyna, Sandra P., Krosschell, Kristin J., Acsadi, Gyula, Elsheik, Bakri, Schroth, Mary K., D'Anjou, Guy, LaSalle, Bernard, Prior, Thomas W., Sorenson, Susan L., Maczulski, Jo Anne, Bromberg, Mark B., Chan, Gary M., Kissel, John T.
Publicado 2010

Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study

por Kolb, Stephen J., Coffey, Christopher S., Yankey, Jon W., Krosschell, Kristin, Arnold, W. David, Rutkove, Seward B., Swoboda, Kathryn J., Reyna, Sandra P., Sakonju, Ai, Darras, Basil T., Shell, Richard, Kuntz, Nancy, Castro, Diana, Iannaccone, Susan T., Parsons, Julie, Connolly, Anne M., Chiriboga, Claudia A., McDonald, Craig, Burnette, W. Bryan, Werner, Klaus, Thangarajh, Mathula, Shieh, Perry B., Finanger, Erika, Cudkowicz, Merit E., McGovern, Michelle M., McNeil, D. Elizabeth, Finkel, Richard, Kaye, Edward, Kingsley, Allison, Renusch, Samantha R., McGovern, Vicki L., Wang, Xueqian, Zaworski, Phillip G., Prior, Thomas W., Burghes, Arthur H.M., Bartlett, Amy, Kissel, John T.
Publicado 2016